Horizon Therapeutics: Q1 Earnings Insights

Horizon Therapeutics NASDAQ:HZNP reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Horizon Therapeutics beat estimated earnings by 11.67%, reporting an EPS of $1.34 versus an estimate of $1.2.

Revenue was up $542.84 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 1.28% increase in the share price the next day.

Here's a look at Horizon Therapeutics's past performance:

To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.